Vanguard Group Inc Increases Stake in Microbot Medical Inc

The Vanguard Group Inc has filed an amended Schedule 13G/A with the SEC, disclosing an increased stake in Microbot Medical Inc. As of September 30, 2025, Vanguard holds 2,343,561 shares, representing a 4.45% ownership in the company. This marks an increase of 292,923 shares from their previous filing, with the value of the holdings rising by $58,533.03 to $5,226,141.03. The filing indicates that Vanguard's clients, including investment companies and managed accounts, have the right to receive dividends or proceeds from the sale of these securities. The amendment was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.